{"id":168718,"date":"2025-06-09T08:47:42","date_gmt":"2025-06-09T12:47:42","guid":{"rendered":"https:\/\/44.250.171.167\/?p=168718"},"modified":"2025-06-09T08:47:42","modified_gmt":"2025-06-09T12:47:42","slug":"mankind-pharma-ltd-q4fy25-11-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/mankind-pharma-ltd-q4fy25-11-fall-in-profits\/","title":{"rendered":"Mankind Pharma Ltd Q4FY25; 11% fall in Profits"},"content":{"rendered":"<p>Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.<\/p>\n<h2>\nFinancial Results:<\/h2>\n<p>Mankind Pharma Ltd reported Revenues for Q4FY25 of \u20b93,079.00 Crores up from \u20b92,422.00 Crore year on year, a rise of 27.13%.<\/p>\n<p>Total Expenses for Q4FY25 of \u20b92,818.00 Crores up from \u20b91,945.00 Crores year on year, a rise of 44.88%.<\/p>\n<p>Consolidated Net Profit of \u20b9425.00 Crores down 10.9% from \u20b9477.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b910.20, down 13.27% from \u20b911.76 in the same quarter of the previous year.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-168719\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-4-839x1024.png\" alt=\"\" width=\"640\" height=\"781\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-4-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-4-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-4-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-4-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-4.png 1489w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products. Financial Results: Mankind Pharma Ltd reported Revenues for Q4FY25 of \u20b93,079.00 Crores up from \u20b92,422.00 Crore year on year, a rise of 27.13%. Total Expenses for Q4FY25 of \u20b92,818.00 Crores up [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":168719,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[11776,1115,12688],"class_list":["post-168718","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-active-pharmaceutical-ingredients","tag-pharmaceuticals","tag-therapeutics"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/2-4.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":168730,"url":"https:\/\/alphastreet.com\/india\/astrazeneca-pharma-india-ltd-q4fy25-3-rise-in-revenue\/","url_meta":{"origin":168718,"position":0},"title":"Astrazeneca Pharma India Ltd Q4FY25; 3% rise in Revenue","author":"Divyansh_Kasana","date":"June 10, 2025","format":false,"excerpt":"AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India Ltd reported Revenues for Q4FY25 of \u20b91,000.00 Crores up from \u20b9974.00 Crore year on year, a rise of 2.67%. Total Expenses for Q4FY25 of \u20b9914.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168654,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q4fy25-11-rise-in-profits\/","url_meta":{"origin":168718,"position":1},"title":"Ajanta Pharma Ltd Q4FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"June 5, 2025","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q4FY25 of \u20b91,170.00 Crores up from \u20b91,054.00 Crore year on year, a rise of 11.01%. Total Expenses for Q4FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168736,"url":"https:\/\/alphastreet.com\/india\/aurobindo-pharma-ltd-q4fy25-0-fall-in-profits\/","url_meta":{"origin":168718,"position":2},"title":"Aurobindo Pharma Ltd Q4FY25; 0% fall in Profits","author":"Divyansh_Kasana","date":"June 10, 2025","format":false,"excerpt":"Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159) Financial Results: Aurobindo Pharma Ltd reported Revenues for Q4FY25 of \u20b98,382.00 Crores up from \u20b97,580.00 Crore year on year, a rise of 10.58%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166916,"url":"https:\/\/alphastreet.com\/india\/mankind-pharma-ltd-q3fy25-15-fall-in-profits\/","url_meta":{"origin":168718,"position":3},"title":"Mankind Pharma Ltd Q3FY25; 15% fall in Profits","author":"Chirag Gupta","date":"February 17, 2025","format":false,"excerpt":"Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products. Financial Results: Mankind Pharma Ltd reported Revenues for Q3FY25 of \u20b92,397.00 Crores up from \u20b92,209.00 Crore year on year, a rise of 8.51%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-11.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-11.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-11.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-11.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-11.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/2-11.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165716,"url":"https:\/\/alphastreet.com\/india\/mankind-pharma-ltd-q2fy25-34-rise-in-profits\/","url_meta":{"origin":168718,"position":4},"title":"Mankind Pharma Ltd Q2FY25; 34% rise in Profits","author":"Chirag Gupta","date":"November 19, 2024","format":false,"excerpt":"Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products. Financial Results: Mankind Pharma Ltd reported Revenues for Q2FY25 of \u20b92,530.00 Crores up from \u20b92,260.00 Crore year on year, a rise of 11.95%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/download-15.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":163593,"url":"https:\/\/alphastreet.com\/india\/mankind-pharma-ltd-q1fy25-25-rise-in-profits\/","url_meta":{"origin":168718,"position":5},"title":"Mankind Pharma Ltd Q1FY25; 25% rise in Profits","author":"Chirag Gupta","date":"August 5, 2024","format":false,"excerpt":"Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products. Financial Results: Mankind Pharma Ltd reported Revenues for Q1FY25 of \u20b92,403.00 Crores up from \u20b92,092.00 Crore year on year, a rise of 14.87%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-26.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-26.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-26.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-26.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-26.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-26.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=168718"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168718\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/168719"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=168718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=168718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=168718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}